Other top stories

The Advantages of Long-Acting Injectables in Early-Phase Schizophrenia

Smiley Emojis Sometimes Mask Sad Feelings, Study Finds

The Weekly Mind Reader: Ghrelin, Anxiety, and Disordered Eating

Experimental Alzheimer's Drug Donanemab Shows Promise in Slowing Cognitive Decline

A Reason for Hope in Rett Syndrome: New Medications, Novel Gene Therapies

Slow-Release UZEDY Gains FDA Approval, Reduces Schizophrenia Relapse by 80%